Literature DB >> 6698602

Activation of human complement by the pneumococcal toxin pneumolysin.

J C Paton, B Rowan-Kelly, A Ferrante.   

Abstract

Highly purified pneumolysin (at a concentration of 10 micrograms/ml) caused significant activation of human complement, as measured by conversion of C3. Complement activation in the presence of pneumolysin was not observed in sera chelated with a combination of Mg2+ and ethylene glycol-bis(beta-aminoethyl ether)-N,N-tetraacetic acid, and activation was only slight in C2-deficient sera. This suggests that the toxin is capable of activating the classical complement pathway. Treatment of normal human serum with pneumolysin also significantly reduced its opsonic activity for Streptococcus pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698602      PMCID: PMC264298          DOI: 10.1128/iai.43.3.1085-1087.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.

Authors:  J A Winkelstein; A Tomasz
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  Interaction of pneumococcal antigens with complement in rats.

Authors:  J D Coonrod; S Jenkins
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

3.  Complement levels in pneumococcal pneumonia.

Authors:  J D Coonrod; B Rylko-Bauer
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

4.  Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin.

Authors:  J C Paton; A Ferrante
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

5.  Complement activation by pneumococci associated with acute otitis media.

Authors:  K Prellner
Journal:  Acta Pathol Microbiol Scand C       Date:  1979-06

6.  Complement system in pneumococcal infections.

Authors:  W P Reed; M S Davidson; R C Williams
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

7.  Pulmonary injury induced by C3a and C5a anaphylatoxins.

Authors:  N P Stimler; T E Hugli; C M Bloor
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

8.  Homozygous deficiency of the second component of complement presenting with recurrent bacterial meningitis.

Authors:  Y H Thong; D A Simpson; H J Müller-Eberhard
Journal:  Arch Dis Child       Date:  1980-06       Impact factor: 3.791

9.  Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.

Authors:  K K Matthay; W C Mentzer; D W Wara; H K Preisler; N B Lameris; A J Ammann
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

10.  The critical role of complement in experimental pneumococcal sepsis.

Authors:  S W Hosea; E J Brown; M M Frank
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

View more
  93 in total

1.  An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence.

Authors:  B H Jost; J G Songer; S J Billington
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.

Authors:  Hisashi Baba; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Satoshi Ichiyama; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection.

Authors:  Rendong Fang; Kohsuke Tsuchiya; Ikuo Kawamura; Yanna Shen; Hideki Hara; Shunsuke Sakai; Takeshi Yamamoto; Teresa Fernandes-Alnemri; Ruili Yang; Eduardo Hernandez-Cuellar; Sita R Dewamitta; Yanting Xu; Huixin Qu; Emad S Alnemri; Masao Mitsuyama
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

5.  Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Jonathan Fratkin; Hilary Thompson; Mary E Marquart
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

Review 6.  Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.

Authors:  Rodney K Tweten
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 7.  Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial Infection.

Authors:  Bryan van den Broek; Michiel van der Flier; Ronald de Groot; Marien I de Jonge; Jeroen D Langereis
Journal:  J Innate Immun       Date:  2019-07-03       Impact factor: 7.349

8.  Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene.

Authors:  A M Berry; A D Ogunniyi; D C Miller; J C Paton
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

9.  Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin.

Authors:  A Ferrante; B Rowan-Kelly; J C Paton
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Species-specific interaction of Streptococcus pneumoniae with human complement factor H.

Authors:  Ling Lu; Zhuo Ma; T Sakari Jokiranta; Adeline R Whitney; Frank R DeLeo; Jing-Ren Zhang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.